INS and Hyperglycemia: Transgenic mice that over-expressed rat IGFPB1 downstream of the mouse phosphoglycerate kinase promoter have fasting hyperglycemia, hyperinsulinemia and glucose intolerance, possibly due to enhanced gluconeogenesis, hepatic insulin resistance, and increased serum gluconeogenic substrate [71], [72], [73].